The physicians’ organization wants botanical products evaluated through rigorous evidence as FDA gathers feedback on research, manufacturing and regulatory challenges.
Federal registration is moving forward for qualifying medical dispensaries, but the new guidance reaches beyond the storefront to suppliers, records and laboratory testing.
The company’s Canadian cannabis plan pairs production transfers with a higher earnings-guidance floor, while keeping the larger savings and certification targets in the future.
The announced investment adds a Boonton location to Curaleaf’s New Jersey reach, while leaving the ownership percentage, price and customer-facing changes undisclosed.
The new proposal would preserve a pathway already used by 95 businesses, with separate inventory and records and continuing federal uncertainty.
The lightweight main event leads a full Halloween card, with an important distinction for cannabis-minded visitors: legal retail does not mean consumption at a sporting event.
The proposal goes beyond moving cannabis between schedules, pairing descheduling with changes to research oversight, penalties and federal agency authority.
A newly introduced Michigan bill seeks a one-year pause in the 24% wholesale cannabis tax. It would leave separate retail taxes untouched.
Verano’s October 29 results show higher annual sales and a narrower loss, but a comparison with June gives the quarter a different shape.
The signed bill and the promised chapter amendments tell different parts of the story. Existing wage protections remain a separate issue.